Related Experiment Video
Updated: May 25, 2026
07:42
An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
New developments in invasive fungal disease
1Universitätsklinikum Münster, Albert-Schweitzer-St, 33 48149 Münster, Germany. andreash.groll@ukmuenster.de
Future Microbiology
|February 14, 2012
Summary
New research on invasive fungal infections was presented, focusing on treatment advancements and diagnostic tools. Key clinical trials and emerging fungal pathogens were discussed to improve patient outcomes in immunocompromised individuals.
Area of Science:
- Mycology
- Infectious Diseases
- Clinical Research
Background:
- Invasive fungal infections (IFIs) pose significant threats, causing high morbidity and mortality, especially in immunocompromised patients.
- Effective management of IFIs requires continuous updates on treatment strategies and pathogen characteristics.
Purpose of the Study:
- To summarize key findings and research trends in invasive fungal disease presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
- To highlight advancements in diagnostics, therapeutics, and understanding of emerging fungal pathogens.
Main Methods:
- Review of clinical trial data presented at the 51st ICAAC.
- Analysis of presentations on novel diagnostic tools and therapeutic drug monitoring.
- Compilation of updates on emerging fungal pathogens.
Main Results:
- Several important clinical trials for invasive fungal infections were reported.
- New diagnostic tools and therapeutic drug monitoring strategies for azoles were discussed.
- Updates on several emerging fungal pathogens were presented, offering insights into their characteristics and management.
Conclusions:
- The 51st ICAAC showcased significant progress in understanding and treating invasive fungal infections.
- Continued research into diagnostics, therapeutics, and emerging pathogens is crucial for improving patient care.
Related Concept Videos
01:28Fungal Phylum Microsporidia
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...